Loxo Oncology, Inc. LOXO
We take great care to ensure that the data presented and summarized in this overview for Loxo Oncology, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in LOXO
Top Purchases
Top Sells
About LOXO
Insider Transactions at LOXO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2017
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
250,000
-20.99%
|
$20,500,000
$82.5 P/Share
|
|
Nov 22
2017
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
267,000
-18.31%
|
$20,025,000
$75.0 P/Share
|
|
Nov 16
2017
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
270,000
-3.32%
|
$19,980,000
$74.41 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders